Crossmark

Amikacin use in critically ill patients requiring renal replacement therapy: the AMIDIAL-ICU study

Crossref DOI link: https://doi.org/10.1186/s13613-025-01461-z

Published Print: 2025

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Dupont, Vincent https://orcid.org/0000-0003-4264-494X
Mourvillier, Bruno

Barbe, Coralie

Legros, Vincent

Jozwiak, Mathieu

Merdji, Hamid

Dupuis, Claire

Winiszewski, Hadrien

Marchalot, Antoine

Lacave, Guillaume

Neuville, Mathilde

Sagnier, Anne

Barbier, François

Thivilier, Carine

Ruiz, Stéphanie

Smonig, Roland

Rosman, Jeremy

Argaud, Laurent

Grangé, Steven

Sarton, Benjamine

Chillet, Patrick

Voiriot, Guillaume

Kanagaratnam, Lukshe

Djerada, Zoubir
License Information

Text and Data Mining valid from 2025-01-01

Text and Data Mining valid from 2025-01-01

Version of Record valid from 2025-11-17
More Information

This article is maintained by: Elsevier

Article Title: Amikacin use in critically ill patients requiring renal replacement therapy: the AMIDIAL-ICU study

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-025-01461-z

Content Type: article

Copyright: Copyright © 2025 The Author(s) 2025. Published by Elsevier Masson SAS